The risk is similar for both, though tirzepatide may have slightly better glucose control, which paradoxically increases hypoglycemia risk with concurrent insulin use
If GLP-1s can help reduce the effective dose levels for these vital treatments, that may be broadly beneficial for the health of patients
This project received funding from the National Research, Development and Innovation Office and co-funded by the European Union NextGenerationEU under the umbrella of the Partnership Fostering a European Research Area for Health (ERA4Health) (GA N 101095426 of the EU Horizon Europe Research and Innovation Programme), and by the Momentum Research Grant from the Hungarian Academy of Sciences (LP-202114)
Keep a log of nausea, bowel changes, and energy levels so your clinician can modify the dose or add supportive care if needed
They want to know whether there are services that can complement their nutritional efforts and support their body as they work toward a healthier weight
Planned Parenthood states that getting an IUD can cost up to $1,300